Clinical Trial Update: Stem Cell Transplant for Hematologic Diseases [Phase 1, Phase 2]

View source ↗

Summary

A Baylor College of Medicine-sponsored Phase 1/2 trial evaluating stem cell transplant for hematologic malignancies was terminated, with results posted in Octob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hematologic Malignancies | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-10-22